However, individual variability in albumin levels, metabolic rate, and overall health status can contribute to minor differences in how long the medication remains active
What if my product arrives damaged or the seal is broken
Key Takeaways Retatrutide targets three hormones (GLP-1, GIP, glucagon), tirzepatide targets two (GLP-1, GIP), and semaglutide targets one (GLP-1) At 68 weeks, retatrutide achieved 28.7% average weight loss, tirzepatide approximately 22%, and semaglutide around 17% on the highest doses Side effects are similar across all three medications, mainly digestive issues like nausea and diarrhoea Retatrutide is not yet approved and won't be available until mid-2026 at the earliest Retatrutide is not yet approved and is not currently available in the UK Tirzepatide (Mounjaro) and semaglutide (Wegovy) are both available now in the UK through NHS or private providers By entering I agree to the Terms and Conditions
If you notice that your body is responding to your weight loss routine differently from how it used to, you may need to adjust to a change in your metabolism and adapt your diet or exercise routine
He said some of the links already emerging were surprising, suggesting the medications may influence far more than appetite and weight